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The objective of the present study was to evaluate the effect of four non-antibiotic 
antibacterials alone or in combination with cephradine in buffaloes on milk yield of 
mastitis affected quarters. For this purpose, 270 clinically mastitic quarters were 
grouped in randomized pattern. Non-antibiotic antibacterials viz., 2.5% 
chlorpromazine (2 ml), 4% lidocaine (10 ml), 10% povidone-iodine (10 ml) and 
99.5% dimethylsulphoxide (20 ml) alone and in combination with first generation 
cephalosporin (cephradine 500 mg) were instilled into clinically mastitic quarters 
daily for five days. The group administered cephradine alone served as control. 
Mean milk yield (L/quarter per day) was recorded before administration of 
treatment and over a period of 4 weeks post initiation of treatment. Among the 4 
non-antibiotic antibacterials tested alone, chlorpromazine (CPZ) showed 
significantly higher (P<0.05) recuperative effect on the milk yield of clinically 
mastitic quarters of dairy buffaloes. However, dimethylsulphoxide (DMSO) when 
infused alone, further aggravated (P<0.05) the milk yield loss, indicating negative 
effect on milk yield improvement. Adjuncting cephradine with each of the non-
antibiotic antibacterials, the lidocaine-cephradine group showed the highest effect 
(p<0.05) on net recovery of milk yield on day 28 post initiation of treatment. It was 
concluded that that CPZ can be used in clinical mastitis in buffaloes as a low cost 
alternative to expensive branded antibiotics. Further, the use of lidocaine with 
cepheradnie was superior to all other combination regimens in milk yield recovery. 
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INTRODUCTION 
 
Mastitis is the most common and economically the 
most important disease of the dairy industry throughout 
the world (Sharif and Muhammad 2009). Bubaline 
mastitis is the disease of milk producing organ of dairy 
buffalo (Bubalus bubalis) which is also called the ‘black 
gold’ of South Asia, where 95% of the buffalo milk is 
produced (Javaid et al., 2009). Buffalo is also recognized 
as the world second most important milk producing 
species (McDowell et al., 1995; Bhatti et al., 2009). 
Mastitis is the single most common reason for antibiotics 
use in lactating dairy animals (Erskine et al., 2004). 
However, the poor treatment response of mastitis to 
antibiotics therapy is a major area of concern for dairy 
farmers, veterinarians and mastitis researchers. The use of 
antibiotics for mastitis treatment is attendant with the 
following important problems: i) Response to antibiotic 
therapy, in particular in quarters infected with Staphy- 
lococcus aureus, is generally very poor, and 
bacteriological cure rates in clinical S. aureus mastitis 
vary from 9.7 to 52% (Sole et al., 1994; Sole et al., 2000), 
ii) Antibacterial therapy of mastitis has been incriminated 
as a catalyst for developing resistance in pathogenic 
bacteria both in treated and healthy individuals within a 
herd (Berghash et al., 1983; Griggs et al., 1994; Teuber, 
2001) and iii) The use of antibiotics for mastitis treatment 
is one of the most important causes of violative antibiotic 
residues in milk and meat of treated animals (Erskine, 
1996).   
Thus, there is a pressing need to try some alternative 
compounds endowed with antibacterial properties to 
overcome these problems. Recently, a variety of 
compounds commonly employed in the treatment of 
pathological conditions of non-infectious etiology have 
been shown to modify cell permeability and to exhibit Pakistan Vet. J., 2010, 30(1): 39-43. 
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broad-spectrum antimicrobial activity in vitro against 
bacteria and other micro-organisms (Cederiund and 
Mardh, 1993; Martin et al., 2008). Such compounds have 
been given the name 'non-antibiotics' (Kristiansen and 
Amaral, 1997). In addition, these compounds have been 
found to enhance the in vitro activity of certain antibiotics 
against specific bacteria (Kristiansen, 1990), to render in 
vitro antibiotic-resistant bacteria susceptible to previously 
ineffective drugs (Kristiansen et al., 2007; Martins et al., 
2008) and to exhibit strong in vitro antimycobacterial 
activity against clinical strains resistant to one or more 
conventional antibiotics (Kristiansen, 1990; Williams, 
1995; Rodgrigues et al., 2008). These compounds, 
primarily phenothiazines, thioxanthenes and other agents 
with affinities for cellular transport systems, are 
characterized by their effects on the plasma membrane of 
eukaryotic cells (Martin et al. 2008) and have been termed 
membrane stabilizers (Kristiansen, 1990). Martin et al. 
(2008) have reviewed the potential role of non-antibiotics 
(helper compounds) in the treatment of multidrug-
resistant gram-negative infections.  
However, these compounds have not been evaluated 
in the treatment of mastitis. The objective of the present 
preliminary study was to determine the effect of infusions 
of 4 non-antibiotic antibacterials (chlorpromazine, 
lidocaine, povidone-iodine and dimethylsulphoxide) with 
and without cephradine (a first generation cephalosporin) 
on milk yield improvement in mastitic quarters in dairy 
buffaloes after treatment with these compounds. 
 
MATERIALS AND METHODS 
 
A total of 270 clinically mastitic quarters of 249 Nili-
Ravi lactating dairy buffaloes (Bubalus bubalis) were 
selected. Foremilk samples from the affected quarters 
were collected for bacteriological examination before 
initiation of treatment and then on day 28 post initiation of 
treatment (National Mastitis Council, Inc. 1990). 
Principles of the design of clinical trials with special 
reference to mastitis therapy, as described by International 
Dairy Federation (Thorburn, 1990), were followed for 
selecting trial quarters and their allocation to different 
treatments and control groups by randomization. Animals 
previously treated for mastitis during the current lactation 
were not included in the panel of experimental subjects. 
Similarly, only those quarters were selected which had 
contralateral normal quarters.   
Animals selected were from buffaloes managed at the 
Livestock Experimental Station, University of 
Agriculture, Faisalabad and six private buffalo dairy 
farms. All experimental buffaloes were managed in tie-
stall and loose housing system during the experimental 
period. These buffaloes received a diet of concentrate 
mixture and green fodder. In a cut-and-carry feeding 
system, chopped green fodder plus chaffed wheat straw 
were fed. Standard mastitis control practices (e.g. post 
milking antiseptic teat dipping, dry period antibiotic 
therapy, segregation or culling of mastitic animals) were 
not in practice at any of the farms. 
The milk yield of the quarters affected with mastitis 
was subtracted from the milk yield of contralateral normal 
quarters before infusion of non-antibiotic antibacterials 
into mastitic quarters. Similarly, the milk yield of mastitis 
affected quarters treated with non-antibiotics was 
subtracted from the milk yield of opposite normal quarter. 
Usually, treated quarters do not regain their milk 
production in a week or two. So, a period of 28 days after 
the commencement of treatment was adopted for milk 
yield record to compare the mean yield of different 
groups. 
The present study involved two experiments. The 
experiment 1 aimed at evaluation of non-antibiotic 
antibacterials alone in the treatment of bubaline clinical 
mastitis. For this purpose, 30 mastitic quarters were 
treated by intramammary route with each of the 4 non-
antibiotic antibacterials (Table 1), using human 
intravenous catheter no. 22 (Vasocan Braunule™) 
attached to 50 ml plastic syringe. Only 2-3 mm anterior 
tip of the catheter was introduced into the teat (partial 
insertion) for infusion.   
Immediately before treatment, mean milk yields of 
the mastitis quarters as well as opposite normal quarters 
were recorded. Similarly, at day 28 post initiation of 
treatment, mean milk yield of treated quarters and 
contralateral normal quarters were recorded. 
    
Table 1: Evaluation of non-antibiotic antibacterials alone in the treatment of bubaline clinical mastitis 
Non-antibiotic 
antibacterials  Product and manufacturer 
Volume and amount 
infused into each 
quarter per day 
No. of  
quarters  
infused 
Duration 
of  
treatment 
(days) 
Chlropromazine HCl 
 (CPZ) 
Inj. Largactil
TM,  
Aventis Pharma, Pakistan 
2 ml (50mg) + 38 ml 
normal saline  
30 5 
Lidocaine HCl 
(Lid) 
Xylocaine
TM (4%)  
Barrett Hodgson, Pakistan 
10 ml + 30 ml  
normal saline 
30 5 
Povidone-iodine 
 (PI) 
Pyodine
TM solution (10%), 
Brookes Pharmaceutical Lab., 
Pakistan 
10 ml + 30 ml 
normal saline 
30 5 
Dimethylsulphoxide 
(DMSO) 
Dimethylsulphoxide  
(99.5%) Sigma-Aldrich, GhbH, 
Germany 
20 ml + 20 ml  
normal saline 
30 5 
Cephradine (control) 
(Ceph) 
Inj. Velosef, Bristol-Mayer
,s  
Squibb, Pakistan 
500 mg + 40 ml 
normal saline 
30 5 
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Experiment II involved the evaluation of non-
antibiotic antibacterials in combination with antibiotic 
(cephradine) in the treatment of bubaline clinical mastitis. 
All 4 non-antibiotic antibacterials (chlorpromazine, 
lidocaine, povidone-iodine and dimethylsulphoxide) were 
evaluated in regimens similar to those in experiment I, 
except that 500 mg cephradine (Inj. Velosef
TM, Bristol-
Myers Squibb, Pakistan) was added to daily infusions of 
each non-antibiotics antibacterial in 30 mastitis quarter in 
each group. Mean milk yield loss of the affected quarters 
was analyzed by analysis of variance to compare means 
before and after treatment (Steel et al., 1997).     
 
RESULTS AND DISCUSSION 
 
The overall effects of infusions of non-antibiotic 
antibacterials with and without cephradine on milk yield 
of the buffalo quarters affected with mastitis are shown in 
Table 2. Statistical prioritization of mean milk yield loss 
before and at day 28 post-initiation of treatment is given 
in Table 3.  
The pre-treatment milk yield losses in quarters 
treated with CPZ, Lid, PI and DMSO alone were 31.69, 
30.06, 33.08 and 24.80%, respectively. The corresponding 
values on day 28 post-initiation of treatment were 16.31, 
22.53, 27.4 and 34.55% (Table 2).  
Thus, the highest percent net recovery of milk yield 
was observed in CPZ group (15.38), followed by Lid 
(7.53) and PI (5.68) group. Contrarily, in DMSO treated 
group, the milk yield loss increased further instead of 
decline. In other words, a significant (P<0.05) reduction 
(Table 3) in losses of milk yield was observed in CPZ 
group as compared to other treatment groups. This may be 
due to strong antibacterial effect of CPZ (Williams, 1995; 
Amaral et al., 1996; Martins et al., 2008). On the other 
hand, the quarters treated with DMSO registered a further 
significant (P<0.05) increase in loss of milk yield. This 
may be attributed to inability of dimethylsulphoxide to 
control bacterial infections, as this chemical possesses 
only a weak antibacterial activity (Plumb, 1999). The net 
recovery of milk yield in quarters treated with povidone-
iodine was very poor (5.68%), which might have been due 
to its irritability on udder tissue. Udder irritation produced 
by antimastitic preparations is one of the main criteria in 
the evaluation experiments (Muhammad et al., 1990). 
More irritant the drug, the lesser it is desirable for 
intramammary infusion (Uvrov, 1971).  
In the present study, although all four non-antibiotic 
antibacterials with and without cephradine were 
administered by intramammary infusion, no attempt was 
made to study their comparative irritability in terms of 
increases in milk somatic cell counts. This is one of the 
shortcomings of the present study which should be 
addressed in any similar future investigation on the use of 
non-antibiotic antibacterials in mastitis treatment. Milk 
somatic cell count has been shown to increase due to 
mastitis (Khan and Khan, 2006; Sharif et al., 2007). 
Considering combination regimens (Table 2), the 
pre-treatment milk yield losses in quarters treated with 
CPZ, Lid, PI and DMSO in combination with cephradine 
were 29.10, 34.75, 31.42 and 33.10%, respectively. The 
corresponding values on day 28 post-initiation of 
treatment were 11.85, 13.47, 19.01 and 15.38%, with a 
resultant net recovery of milk yields of 17.25, 21.28, 
12.41 and 17.72%. 
   
Table 2: Effect of four non-antibiotic antibacterials infusions alone and in combination with cephradine on milk 
yield in buffaloes over a period of 4 weeks post initiation of treatment 
CPZ = Chlorpromazine, Lid = Lidocaine, DMSO = Dimethylsulphoxide PI = Povidone – iodine, Ceph = Cephradine 
A = Pre-treatment; B = Post-treatment 
Non-antibiotic 
antibacterials 
alone and in 
combination with 
cephradine  
Milk yield of mastitic 
quarters before and 
after treatment 
Milk yield of 
contralateral 
normal 
quarters 
Difference of 
mean 
Reduction in 
milk yield loss 
of affected 
quarters (%) 
Net recovery 
of milk yield 
of treated 
quarters on 
day 28 (%) 
CPZ      A   0.97 ± 0.10 
B   1.18 ± 0.13 
1.42 ± 0.11 
1.41 ± 0.11 
0.45 ± 0.05 
0.23 ± 0.07 
31.69 
16.31 
15.38 
Lid    A     1.0 ± 0.09 
B   1.10 ± 0.07 
1.43 ± 0.11 
1.42 ± 0.09 
0.43 ± 0.12 
0.32 ± 0.02 
30.06 
22.53 
7.53 
PI  A   0.89 ± 0.11 
B   0.98 ± 0.17 
1.33 ± 0.12 
1.35 ± 0.11 
0.44 ± 0.08 
0.37 ± 0.11 
33.08 
27.4 
5.68 
DMSO  A   1.03 ± 0.07 
B   0.89 ± 0.08 
1.37 ± 0.07 
1.36 ± 0.07 
0.34 ± 0.09 
0.47 ± 0.08 
24.8 
34.55 
-9.75 
Ceph (control)  A   0.95 ± 0.09 
B   1.16 ± 0.13 
1.45 ± 0.09 
1.46 ± 0.08 
0.50 ± 0.08 
0.30± 0.09 
34.48 
20.54 
13.94 
CPZ + Ceph  A   0.95 ± 0.12 
B   1.19 ± 0.11 
1.34 ± 0.10 
1.35 ± 0.10 
0.39 ± 0.06 
0.16 ± 0.09 
29.10 
11.85 
17.25 
Lid+ Ceph   A   0.92 ± 0.11 
B   1.22 ± 0.14 
1.41 ± 0.10 
1.41 ± 0.10 
0.49 ± 0.10 
0.19 ± 0.08 
34.75 
13.47 
21.28 
Pi + Ceph   A   0.96 ± 0.26 
B    1.15 ± 0.11 
1.40 ± 0.11 
1.42 ± 0.11 
0.44 ± 0.07 
0.27 ± 0.07 
31.42 
19.01 
12.41 
DMSO + Ceph   A   0.97 ± 0.19 
B   1.21 ± 0.14 
1.45 ± 0.10 
1.43 ± 0.09 
0.48 ±  0.10 
0.22 ±  0.12 
33.10 
15.38 
17.72 Pakistan Vet. J., 2010, 30(1): 39-43. 
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Table 3: Comparison of different treatments on the basis of mean milk yield loss (mean ± SE) of buffalo mastitic 
quarters 
Non-antibiotic antibacterials alone/ and in 
combination with cephradine 
Pre-treatment milk  yield 
loss 
(L/quarter/day) 
Post-treatment milk  
yield loss 
(L/quarter/day) 
CPZ     0.45 ± 0.05 abc    0.23 ± 0.07 hi 
Lid  0.43 ± 0.12 c   0.32 ± 0.02 ef 
PI    0.44 ± 0.08 bc    0.37 ± 0.11 de 
DMSO     0.34 ± 0.09 def      0.47 ± 0.08 abc 
Cephradine  (control)  0.50 ± 0.08 a    0.30 ± 0.09 fb 
CPZ + cephradine  0.39 ± 0.06 d   0.16 ± 0.09 j 
Lid+ cephradine    0.49 ± 0.10 ab    0.19 ± 0.08 ij 
PI + cephradine    0.44 ± 0.07 bc       0.27 ± 0.07 gh 
DMSO + cephradine    0.48 ± 0.10 ab      0.22 ± 0.12 hi 
Means sharing different letters in a column or row are significantly different (P<0.05). 
CPZ = Chlorpromazine HCl; Lid = Lidocaine HCl; PI = Povidone - Iodine; DMSO = Dimethylsulphoxide   
 
Thus, the highest net recovery of milk yield on day 
28 post-initiation of treatment was 21.28% for Lid + Ceph 
group, followed DMSO + Ceph, CPZ + Ceph and PI + 
Ceph groups. Among the quarters receiving combination 
treatments, higher reduction (P<0.05) in the loss of milk 
yield was observed in Lid + Ceph, group (Table 3) 
compared to other treatment groups. This may be due to 
strong antibacterial effect of lidocaine against Gram 
negative bacteria and that of cephradine against Gram 
positive bacteria (Schmidt and Rosenkranz, 1970).  
In summary, among the 4 non-antibiotic anti- 
bacterials tested alone, chlopromazine showed a relatively 
more promising recuperative effect on the milk yield of 
clinically mastitic quarters of dairy buffaloes. 
Dimethylsulphoxide, when infused alone, aggravated the 
milk loss of clinically mastitic quarters. Adjuncting 
cephradine with each of the 4 non-antibiotic antibacterials 
showed that the lidocaine-cephradine combination had the 
highest effect (P<0.05) on the net recovery of milk yield 
loss at day 28 post initiation of treatment. 
The present study was the first one on the use of 
chlorpromazine and lidocaine in the treatment of mastitis. 
In view of a small number of quarters (n=30) on which 
each of the 4 non-antibiotic antibacterials were tested, a 
larger field trials involving a larger number of mastitis 
affected animals and quarters is clearly warranted. 
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